approval · primary record
CAPLACIZUMAB-YHDP
FDA · BLA · 2025-12-23
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-12-23 |
| Brand | CABLIVI |
| Sponsor | ABLYNX NV |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:32.229Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CAPLACIZUMAB-YHDP:2025-12-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.